YGYvan Gomez

Yvan Gomez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yvan Gomez has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Advances in automated fetal brain MRI segmentation and biometry: Insights from the FeTA 2024 challenge

    by Vladyslav Zalevskyi, Thomas Sanchez, Misha Kaandorp, Margaux Roulet, Diego Fajardo-Rojas, Liu Li, Jana Hutter, Hongwei Bran Li, Matthew J. Barkovich, Hui Ji, et al.


  • Open Access

    Dual Effect of Melatonin in Fetal Brain: Structural and Cellular Implications in a Rabbit Model of Intrauterine Growth Restriction

    by Laia Guardia-Escote, Yvan Gómez, Mercè Fuentes-Amell, Carlota Rovira, Eduard Gratacós, Britta Anna Kühne, Marta Barenys, Miriam Illa

    Intrauterine growth restriction (IUGR) is a condition in which the fetus fails to reach its genetic growth potential, often resulting in neurodevelopmental alterations. This study investigates the neuroprotective potential of gestational melatonin (MEL) treatment using an IUGR rabbit model. IUGR was induced by ligating the uteroplacental vessels of one uterine horn in pregnant rabbits, using the other horn as the control (CNT). Dams received either placebo (PLA) or MEL from gestational day 25 to 30, when pups were delivered by cesarean section. We performed a functional evaluation, followed by placental histopathology, oligodendrocyte quantification, neuronal arborization, and DAB (3, 3'-diaminobenzidine) staining of MEL receptors in the brain. IUGR groups exhibited significantly lower body weights and survival rates than CNTs, confirming successful model induction. Placental analysis indicated higher phase 2 ischemia in IUGR than CNTs, and reduced calcifications in MEL-treated groups. Brain analysis showed fewer oligodendrocytes and MEL receptors in PLA-treated IUGR groups compared to CNTs, partially reversed by MEL treatment. A dual response to MEL was observed in several endpoints, with beneficial effects on IUGR and detrimental effects on CNT groups. In conclusion, MEL demonstrates beneficial effects on the IUGR brain, particularly by increasing oligodendrocyte numbers, but its detrimental effects in CNT groups warrant caution in healthy pregnancies. These results indicate that substances can act as both therapeutic and toxic agents depending on physiological context, underscoring the need for further research to understand MEL’s mechanisms and optimize treatment strategies.

  • Open Access

    Predictive Factors Involved in Postpartum Regressions of Cytological/Histological Cervical High-Grade Dysplasia Diagnosed during Pregnancy

    by Yvan Gomez, Vincent Balaya, Karine Lepigeon, Patrice Mathevet, Martine Jacot-Guillarmod

    Objective: The aim of this study was to describe the evolution of high-grade cervical dysplasia during pregnancy and the postpartum period and to determine factors associated with dysplasia regression. Methods: Pregnant patients diagnosed with high-grade lesions were identified in our tertiary hospital center. High-grade lesions were defined either cytologically, by high squamous intraepithelial lesion/atypical squamous cells being unable to exclude HSIL (HSIL/ASC-H), or histologically, with cervical intraepithelial neoplasia (CIN) 2+ (all CIN 2 and CIN 3) during pregnancy. Postpartum regression was defined cytologically or histologically by at least a one-degree reduction in severity from the antepartum diagnosis. A logistic regression model was applied to determine independent predictive factors for high-grade cervical dysplasia regression after delivery. Results: Between January 2000 and October 2017, 79 patients fulfilled the inclusion criteria and were analyzed. High-grade cervical lesions were diagnosed by cytology in 87% of cases (69/79) and confirmed by histology in 45% of those (31/69). The overall regression rate in our cohort was 43% (34/79). Univariate analysis revealed that parity (p = 0.04), diabetes (p = 0.04) and third trimester cytology (p = 0.009) were associated with dysplasia regression. Nulliparity (OR = 4.35; 95%CI = (1.03–18.42); p= 0.046) was identified by multivariate analysis as an independent predictive factor of high-grade dysplasia regression. The presence of HSIL on third-trimester cervical cytology (OR = 0.17; 95%CI = (0.04–0.72); p = 0.016) was identified as an independent predictive factor of high-grade dysplasia persistence at postpartum. Conclusion: Our regression rate was high, at 43%, for high-grade cervical lesions postpartum. Parity status may have an impact on dysplasia regression during pregnancy. A cervical cytology should be performed at the third trimester to identify patients at risk of CIN persistence after delivery. However, larger cohorts are required to confirm these results.